skrunch

6 ms·

1.
by skrunch 14d ago
Glad I'm not the only one, I was half expecting cards from "Aperture Science" or "Black Mesa" to show up in there.
2.
by skrunch 2mo ago
It's a shame there's the "This site is a parody" footer, I'd be curious if LLMs were to actually fall for this without it, especially if that were to depend on model size.
3.
by skrunch 7mo ago
Would love this with CS1.6 voices: "GO GO GO!", "The bomb has been planted", "Need backup"
4.
by skrunch 9mo ago
Except the image benchmarks are compared against 2.0, which seems suspicious that they would casually drop to an older model for those.
5.
by skrunch 2y ago
Quick, someone let James Hoffman know!
6.
by skrunch 3y ago
Page 72 here: https://publications.europa.eu/resource/cellar/2d5d968f-4f4c... 45-55% in most countries (France seems like an outlier), but even that is above 20%.
7.
by skrunch 4y ago
> PyTorch offers a way to export to ONNX but you will encounter various errors. [1] I mean sure, there are limitations, but this is greatly exaggerating their impact in my experience. I'd be curious to hear from anyone where these h
8.
by skrunch 6y ago
This doesn't exactly answer your question, but what I settled on during my dissertation (granted, that was a few years ago now) was SUMO: https://www.eclipse.org/sumo/ IIRC you could import maps from from open str
9.
by skrunch 6y ago
On the fence about this. On the one hand I agree that sensitive data should stay local, but on the other hand this would make their very valuable asset (the model) public.
10.
by skrunch 7y ago
The visualisation linked to at the end goes into some more detail and was definitely worth the extra 5 minute read for me!
11.
by skrunch 7y ago
There's also a fantastic little cocktail bar called Ladies and Gents in Kentish Town, if you ever find yourself in the area.
12.
by skrunch 7y ago
Shameless plug: https://www.yoti.com/ We're trying to do exactly that.
13.
by skrunch 8y ago
From the article: "In an attempt to understand how the virus works, researchers at the University of Otago in New Zealand discovered in 2017 that the virus binds to a receptor called ANTXR1, which is active in more than 60 percent of t